Hospital
Medical University Hospital Authority
Medical University Hospital Authority was paid $1.43M by Medicaid between Jan 2023 and Dec 2024, across 118 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 21% of everything it billed.
33Billing provider infoMEDICAL UNIVERSITY HOSPITAL AUTHORITY
CADES, SC 29518
CADES, SC 29518
33aNPI1841914298assigned 09/29/2022
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.43M
24GClaims91,668
24DCodes billed118
24AFirst – last monthJan 2023 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#64 of 115
Median peer was paid$2.47M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RAE, KARYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 39,235 | $806K | |
| 2024incomplete | 52,433 | $628K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 21% | 3,535 | 3,375 | $302K |
| 80053 | Comprehensive metabolic panel | 20% | 4,775 | 4,263 | $290K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 13% | 2,542 | 2,429 | $183K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4.6% | 1,170 | 1,070 | $66K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.3% | 5,900 | 5,564 | $61K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.1% | 2,888 | 857 | $59K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.1% | 1,283 | 1,083 | $59K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 2,090 | 1,898 | $32K |
| 81001 | 2.0% | 2,845 | 2,611 | $29K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 598 | 563 | $26K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 1,015 | 948 | $22K |
| 81003 | 1.4% | 1,250 | 1,185 | $21K |
106 more codes
| 99284 | Emergency room visit (serious) | 1.4% | 4,702 | $20K |
| 81025 | 1.4% | 2,001 | $20K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 1,638 | $18K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1.2% | 243 | $17K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 1,073 | $15K |
| 73130 | <1% | 230 | $14K | |
| 82947 | <1% | 990 | $14K | |
| 73630 | <1% | 477 | $13K | |
| 73610 | <1% | 253 | $13K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,328 | $11K |
| 73030 | <1% | 306 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,383 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 752 | $9K |
| 99285 | Emergency room visit (most serious) | <1% | 2,072 | $8K |
| 97014 | <1% | 201 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 384 | $8K |
| 73560 | <1% | 298 | $7K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 570 | $7K |
| 84702 | <1% | 101 | $6K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 52 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 722 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 58 | $5K |
| 80061 | Lipid panel | <1% | 249 | $5K |
| 72100 | <1% | 152 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 811 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,277 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 83 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,031 | $2K |
| 74018 | <1% | 122 | $2K | |
| 87077 | <1% | 258 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,500 | $2K |
| 73562 | <1% | 67 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 778 | $2K |
| 84484 | <1% | 2,267 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 249 | $1K |
| 85379 | <1% | 341 | $1K | |
| 73502 | <1% | 83 | $1K | |
| 85007 | <1% | 418 | $995.45 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,515 | $948.30 |
| 73110 | <1% | 53 | $884.05 | |
| 72040 | <1% | 26 | $842.59 | |
| 84439 | <1% | 229 | $719.88 | |
| 82077 | <1% | 513 | $529.01 | |
| 85610 | <1% | 651 | $483.30 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 677 | $460.86 |
| 97161 | <1% | 303 | $408.10 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 373 | $388.20 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 97 | $367.66 |
| 83880 | <1% | 546 | $325.99 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 640 | $305.18 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 258 | $220.42 |
| 82550 | <1% | 170 | $152.75 | |
| 82248 | <1% | 116 | $148.56 | |
| 83735 | <1% | 2,233 | $127.32 | |
| 87040 | <1% | 603 | $88.01 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 373 | $73.21 |
| 97162 | <1% | 15 | $68.23 | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 20 | $48.61 |
| 97116 | <1% | 22 | $45.87 | |
| 85027 | <1% | 936 | $36.26 | |
| 83690 | <1% | 1,269 | $25.05 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 15 | $10.22 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 280 | $7.38 |
| J2704 | Injection, propofol, 10 mg | <1% | 367 | $6.92 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 151 | $6.46 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,092 | $6.03 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 158 | $5.78 |
| 85730 | <1% | 393 | $5.34 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,131 | $5.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 232 | $4.80 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | <1% | 22 | $4.64 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 82 | $0.18 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 55 | $0.00 |
| 83605 | 0% | 811 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 69 | $0.00 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 169 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 62 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 465 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 66 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,345 | $0.00 |
| 96376 | 0% | 159 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 668 | $0.00 |
| C1769 | Guide wire | 0% | 83 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 39 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 0% | 17 | $0.00 |
| 94644 | 0% | 13 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 51 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 333 | $0.00 |
| 80179 | 0% | 55 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 87 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 240 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 48 | $0.00 |
| 87186 | 0% | 103 | $0.00 | |
| 82805 | 0% | 15 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 18 | $0.00 |
| 80143 | 0% | 80 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 127 | $0.00 |
| 36600 | 0% | 13 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 118 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 261 | $0.00 |
| 90715 | 0% | 25 | $0.00 | |
| 73590 | 0% | 17 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 12 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 15 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 21 | $0.00 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAE, KARYN (CHIEF, PAYOR RELATIONS AND REIMBURS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.